Excilone
France FR-MF-000020745 Last updated 21 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 1
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
PathScan Combi Ref EXCS-PS-C
About
https://www.youtube.com/watch?v=HZRGPX97kYo we sell what we use and use what we sell Digital Pathology Integrated SolutionsSfor fish Pathology SolutionsMolecular Pathology Solutionsfor cytogenetics Nanoparticle Analysis Molecular Genetics..
What Excilone makes
Excilone develops digital pathology integrated solutions, including the PathScan Combi system, which supports automated imaging and analysis of cytogenetic samples. Their offerings also encompass molecular pathology tools for cytogenetics and nanoparticle analysis, as well as molecular genetics applications.
The company’s products fall under EU Class A medical devices and are registered in the EU’s eudamed database. Excilone is based in France and adheres to EU regulatory requirements for these device classifications.
Frequently asked questions
What types of medical devices does Excilone manufacture?
Excilone specializes in digital pathology integrated solutions. Their primary product, the PathScan Combi system, is designed for automated imaging and analysis of cytogenetic samples. Additionally, they offer tools for molecular pathology, including applications in cytogenetics, nanoparticle analysis, and molecular genetics. These devices are developed to streamline workflows in pathology laboratories.
Where is Excilone based, and what regulatory framework does it follow?
Excilone is headquartered in France. Since their devices fall under EU Class A classification, they must comply with the EU Medical Device Regulation (MDR) or the EU In Vitro Diagnostic Regulation (IVDR), depending on the specific product. This classification applies to low-risk devices, which typically require less stringent regulatory oversight but still must meet essential safety and performance requirements.
Are Excilone’s devices listed in any regulatory registries?
Yes, Excilone’s devices are registered in the EU’s eudamed database. This platform is the official EU-wide registry for medical devices, ensuring transparency and traceability of manufacturers, devices, and their regulatory status within the European market. Listing in eudamed is mandatory for manufacturers under EU regulations.
How are Excilone’s devices classified under EU regulations?
Excilone’s devices, including the PathScan Combi system, are classified as EU Class A medical devices. This classification is assigned based on risk assessment criteria outlined in EU regulations. Class A devices are considered the lowest risk, often involving minimal or non-invasive procedures with negligible risk to patients. However, even these devices must still meet fundamental safety and performance requirements to ensure their proper use in clinical settings.
What industries or applications do Excilone’s devices primarily serve?
Excilone’s devices are primarily designed for pathology laboratories, particularly those specializing in cytogenetics, molecular pathology, and digital pathology. Their solutions automate and enhance the analysis of cytogenetic samples and molecular diagnostics, which are critical in fields like oncology, genetics, and reproductive health. By integrating digital imaging and molecular tools, their products aim to improve accuracy, efficiency, and workflow optimization in these specialized areas.
Information
- Country
- France
- Address
- 6, Rue Blaise Pascal, Elancourt, France
- Website
- www.excilone.com
- linkedin.com/company/excilone
- [email protected]
- Phone
- +33134867701
- PRRC contact
- Inayatou Guiry
- EUDAMED SRN
- FR-MF-000020745